Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development

Area of Science:

• Nephrology
• Developmental Biology
• Epigenetics

Background:

• Wilms tumor-1 (WT1) is essential for kidney podocyte development.
• The precise epigenomic mechanisms of WT1 in podocyte development require further elucidation.

Purpose of the Study:

• To map the single-cell epigenomic landscape of WT1 during human kidney development.
• To investigate the functional consequences of WT1 mutations on podocyte development and structure.
• To explore the therapeutic potential of gene editing for WT1-related kidney disorders.

Main Methods:

• Generation of single-cell chromatin accessibility and gene expression maps from fetal kidneys and kidney organoids.
• Creation of patient-derived kidney organoids from induced pluripotent stem cells (iPSCs) with a WT1 mutation.
• Application of single-cell RNA sequencing (scRNA-seq) and functional assays.
• CRISPR-Cas9 gene editing to correct the WT1 mutation in patient iPSCs.

Main Results:

• Identification of key WT1-targeted genes (e.g., BMPER/PAX2/MAGI2, MYH9, NPHS1) crucial for podocyte development and structural integrity.
• Demonstration that WT1 mutations delay podocyte development and cause structural damage by failing to activate essential target genes.
• Confirmation that CRISPR-Cas9 correction of the WT1 mutation in patient iPSCs rescues the podocyte phenotype.

Conclusions:

• This study elucidates the WT1-related epigenomic landscape in human podocyte development.
• WT1 mutations identified as disease-causing, leading to impaired podocyte development and structure.
• Gene editing offers a potential therapeutic strategy for WT1-associated kidney diseases.